Preliminary Findings Suggest New Biomarker For Gliomas May Play An Important Diagnostic Role
Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma - the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The biomarker ELTD1 "may serve as an additional biomarker for gliomas in preclinical and clinical diagnosis of gliomas," according to the study by Rheal A. Towner of Oklahoma Medical Research Foundation, Oklahoma City... (Source: Health News from Medical News Today)
